Developing a solution
for female OAB patients
and
giving them a better
quality of life.

Developing a solution for female OAB patients and giving them a better quality of life.

Where we come from

Inura’s product is an innovative urethral ovulum, a novel route of drug administration, that aims to treat diseases of the bladder and lower urinary tract. Inura’s technology results from decades of work in urology by Professor Grant S. Mulholland.

The journey of Inura started with the vision of Professor Grant S. Mulholland. Prof. Mulholland, was a world renowned urologist who believed women should not have to endure the symptoms of OAB and worked towards trying to improve their lives.

Prof. Mulholland was a medical doctor and urological surgeon with special expertise in infection and urologic oncology. He was passionate and dedicated to the wellbeing of his patients and did everything he could to help them. In addition to running a large clinical practice, he was extremely active in research and publishing throughout his long career. He served as Professor and Chairman of the Department of Urology at a prominent medical school for 25 years.

As a compassionate and caring physician who developed strong relationships with his patients, Prof. Mulholland listened intently to his patients who sought his help, desperate for relief from overactive bladder. His belief was, “Women should NOT have to live like that! There has to be a better way.”

Prof. Mulholland reasoned that a female urethral ovulum could be used as a platform for delivering a well-known drug locally to the bladder without it being absorbed systemically and causing unwanted side effects. He developed and patented this novel ovulum in the U.S., which was brought to Switzerland a few years later.

Unfortunately, Prof. Mulholland passed away in 2015; however, his passion continued to live on within his wife, Betty Mulholland. In 2019, Hemex assumed administrative responsibilities for Inura and appointed Vanja Ivancevic as CEO of the company.

Where we come from

Inura’s product is an innovative urethral ovulum, a novel route of drug administration, that aims to treat diseases of the bladder and lower urinary tract. Inura’s technology results from decades of work in urology by Professor Grant S. Mulholland.

The journey of Inura started with the vision of Professor Grant S. Mulholland. Prof. Mulholland, was a world renowned urologist who believed women should not have to endure the symptoms of OAB and worked towards trying to improve their lives.

Read more

Prof. Mulholland was a medical doctor and urological surgeon with special expertise in infection and urologic oncology. He was passionate and dedicated to the wellbeing of his patients and did everything he could to help them. In addition to running a large clinical practice, he was extremely active in research and publishing throughout his long career. He served as Professor and Chairman of the Department of Urology at a prominent medical school for 25 years.

As a compassionate and caring physician who developed strong relationships with his patients, Prof. Mulholland listened intently to his patients who sought his help, desperate for relief from overactive bladder. His belief was, “Women should NOT have to live like that! There has to be a better way.”

Prof. Mulholland reasoned that a female urethral ovulum could be used as a platform for delivering a well-known drug locally to the bladder without it being absorbed systemically and causing unwanted side effects. He developed and patented this novel ovulum in the U.S., which was brought to Switzerland a few years later.

Unfortunately, Prof. Mulholland passed away in 2015; however, his passion continued to live on within his wife, Betty Mulholland. In 2019, Hemex assumed administrative responsibilities for Inura and appointed Vanja Ivancevic as CEO of the company.

Our team

We are a pharmaceutical startup with a diverse team that is motivated to complete the companies mission of improving the lives of OAB patients.

Vanja Ivancevic

CEO

Dr. Mohamed Hussien

Pharmaceutical Development

Dr. Rafiq Hussain, MD

CMO

Dr. Samidha Kushwaha

Biostatistician & Clinical Operations

Aurelia Altherr

Clinical Development

Andrea O’Callaghan

Clinical Operations

Nycole Gomes

Communications & Marketing Operations

Our team

We are a pharmaceutical startup with a diverse team that is motivated to complete the companies mission of improving the lives of OAB patients.

Vanja Ivancevic

CEO

Dr.
Mohamed Hussien

Pharmaceutical Development

Dr.
Rafiq Hussain, MD

CMO

Dr.
Samidha Kushwaha

Biostatistician & Clinical Operations

Aurelia Altherr

Clinical Development

Andrea O’Callaghan

Clinical Operations

Nycole Gomes

Communications & Marketing Operations

Our collaborators

Our latests achievements

Ranked in the top 7

Mentoring support

Coaching support

Funding support

Ranked in the top 15

Our
collaborators

Our latests achievements

Ranked in the top 15

Mentoring support

Coaching support

Funding support

Ranked in the top 7